论文部分内容阅读
目的探讨采用丹参酮IIA磺酸钠注射液治疗冠心病心绞痛的临床疗效。方法选择我院收治的64例冠心病心绞痛患者为研究对象,随机均分两组,每组32例。对照组采用常规药物治疗方案,试验组在对照组基础上加用丹参酮IIA磺酸钠注射液,对两组治疗后改善心绞痛疗效及改善心电图缺血性ST-T情况进行比较。结果试验组总有效率明显高于对照组,差异具有统计学意义(P<0.05)。治疗后,试验组心绞痛发作频次及心肌缺血性ST-T改善效果优于对照组(P<0.05)。结论丹参酮IIA磺酸钠注射液用于冠心病心绞痛治疗,治疗效果明显,无不良反应,更安全可靠,在临床中具有广泛的应用价值,值得进一步推广。
Objective To investigate the clinical efficacy of sodium tanshinone IIA injection in the treatment of angina pectoris of coronary heart disease. Methods Sixty-four patients with coronary heart disease and angina pectoris treated in our hospital were randomly divided into two groups (n = 32 in each group). The control group was treated with conventional drug therapy. The experimental group was given tanshinone IIA sodium sulfonate injection on the basis of the control group, and the improvement of angina pectoris and improvement of ECG ischemic ST-T were compared between the two groups. Results The total effective rate of the experimental group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). After treatment, the experimental group angina pectoris frequency and myocardial ischemic ST-T improvement better than the control group (P <0.05). Conclusion Sodium tanshinone IIA sulfonate injection for the treatment of coronary heart disease angina pectoris has obvious curative effect, no adverse reaction, more safety and reliability, and has a wide range of clinical value. It is worth to be further popularized.